LGND logo

LGND Shareholders equity

annual shareholders equity:

$830.44M+$129.53M(+18.48%)
December 31, 2024

Summary

  • As of today (June 4, 2025), LGND annual stockholders equity is $830.44 million, with the most recent change of +$129.53 million (+18.48%) on December 31, 2024.
  • During the last 3 years, LGND annual shareholders equity has risen by +$9.28 million (+1.13%).
  • LGND annual shareholders equity is now at all-time high.

Performance

LGND Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

quarterly shareholders equity:

$795.53M-$34.91M(-4.20%)
March 31, 2025

Summary

  • As of today (June 4, 2025), LGND quarterly stockholders equity is $795.53 million, with the most recent change of -$34.91 million (-4.20%) on March 31, 2025.
  • Over the past year, LGND quarterly shareholders equity has dropped by -$10.99 million (-1.36%).
  • LGND quarterly shareholders equity is now -26.34% below its all-time high of $1.08 billion, reached on March 31, 2019.

Performance

LGND quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

LGND Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+18.5%-1.4%
3 y3 years+1.1%+0.3%
5 y5 years+8.2%+20.2%

LGND Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+39.0%-5.4%+33.1%
5 y5-yearat high+39.0%-5.4%+33.1%
alltimeall timeat high+852.1%-26.3%+416.7%

LGND Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
$795.53M(-4.2%)
Dec 2024
$830.44M(+18.5%)
$830.44M(-1.3%)
Sep 2024
-
$841.18M(+8.5%)
Jun 2024
-
$775.20M(-3.9%)
Mar 2024
-
$806.52M(+15.1%)
Dec 2023
$700.91M(+17.3%)
$700.91M(+4.9%)
Sep 2023
-
$667.90M(+0.5%)
Jun 2023
-
$664.89M(+2.9%)
Mar 2023
-
$646.32M(+8.2%)
Dec 2022
$597.49M(-27.2%)
$597.49M(-26.8%)
Sep 2022
-
$816.30M(+1.7%)
Jun 2022
-
$802.37M(+1.2%)
Mar 2022
-
$793.19M(-3.4%)
Dec 2021
$821.16M(+15.7%)
$821.16M(+1.1%)
Sep 2021
-
$812.07M(+3.2%)
Jun 2021
-
$786.52M(+5.5%)
Mar 2021
-
$745.84M(+5.1%)
Dec 2020
$709.52M(-7.5%)
$709.52M(+1.7%)
Sep 2020
-
$697.82M(+0.4%)
Jun 2020
-
$695.00M(+5.0%)
Mar 2020
-
$661.90M(-13.7%)
Dec 2019
$767.23M(+36.8%)
$767.23M(-9.8%)
Sep 2019
-
$850.58M(-18.3%)
Jun 2019
-
$1.04B(-3.6%)
Mar 2019
-
$1.08B(+92.5%)
Dec 2018
$560.91M(+34.0%)
$560.91M(-19.8%)
Sep 2018
-
$699.52M(+12.9%)
Jun 2018
-
$619.81M(+24.7%)
Mar 2018
-
$497.18M(+18.8%)
Dec 2017
$418.65M(+12.9%)
$418.65M(-1.4%)
Sep 2017
-
$424.76M(+3.8%)
Jun 2017
-
$409.41M(+2.7%)
Mar 2017
-
$398.78M(+7.5%)
Dec 2016
$370.85M(+33.9%)
$370.85M(+0.1%)
Sep 2016
-
$370.39M(-5.5%)
Jun 2016
-
$391.92M(-0.0%)
Mar 2016
-
$392.08M(+41.6%)
Dec 2015
$276.91M(+952.2%)
$276.91M(-5.2%)
Sep 2015
-
$292.18M(+323.1%)
Jun 2015
-
$69.05M(+96.5%)
Mar 2015
-
$35.15M(+33.6%)
Dec 2014
$26.32M(-47.0%)
$26.32M(-40.7%)
Sep 2014
-
$44.37M(-30.9%)
Jun 2014
-
$64.17M(-1.3%)
Mar 2014
-
$65.00M(+31.0%)
Dec 2013
$49.61M(+87.3%)
$49.61M(+10.7%)
Sep 2013
-
$44.81M(+14.1%)
Jun 2013
-
$39.27M(+28.3%)
Mar 2013
-
$30.60M(+15.5%)
Dec 2012
$26.48M(+223.6%)
$26.48M(+24.7%)
Sep 2012
-
$21.23M(+15.1%)
Jun 2012
-
$18.45M(-4.1%)
Mar 2012
-
$19.24M(+135.1%)
Dec 2011
$8.19M(-268.8%)
$8.19M(+245.8%)
Sep 2011
-
$2.37M(-55.6%)
Jun 2011
-
$5.33M(+6.3%)
Mar 2011
-
$5.01M(-203.3%)
Dec 2010
-$4.85M(-229.5%)
-$4.85M(-48.6%)
Sep 2010
-
-$9.44M(-455.4%)
Jun 2010
-
$2.66M(+23.8%)
Mar 2010
-
$2.15M(-42.7%)
Dec 2009
$3.74M
$3.74M(-139.4%)
DateAnnualQuarterly
Sep 2009
-
-$9.50M(-22.5%)
Jun 2009
-
-$12.26M(-16.6%)
Mar 2009
-
-$14.70M(+41.8%)
Dec 2008
-$10.37M(-135.6%)
-$10.37M(-630.5%)
Sep 2008
-
$1.95M(-89.7%)
Jun 2008
-
$19.02M(-22.5%)
Mar 2008
-
$24.53M(-15.7%)
Dec 2007
$29.11M(+6.4%)
$29.11M(+10.7%)
Sep 2007
-
$26.29M(-23.2%)
Jun 2007
-
$34.23M(-40.4%)
Mar 2007
-
$57.40M(+109.9%)
Dec 2006
$27.35M(-124.8%)
$27.35M(-110.9%)
Sep 2006
-
-$251.19M(+5.3%)
Jun 2006
-
-$238.50M(+6.3%)
Mar 2006
-
-$224.36M(+103.2%)
Dec 2005
-$110.42M(+46.6%)
-$110.42M(+1.8%)
Sep 2005
-
-$108.41M(+5.9%)
Jun 2005
-
-$102.39M(+9.0%)
Mar 2005
-
-$93.96M(+24.7%)
Dec 2004
-$75.32M(+100.6%)
-$75.32M(-283.9%)
Sep 2004
-
$40.96M(-14.7%)
Jun 2004
-
$48.00M(-20.5%)
Mar 2004
-
$60.37M(-260.8%)
Dec 2003
-$37.55M(-150.7%)
-$37.55M(-160.0%)
Sep 2003
-
$62.60M(+131.3%)
Jun 2003
-
$27.06M(-28.8%)
Mar 2003
-
$38.02M(-48.6%)
Dec 2002
$74.02M(-227.9%)
$74.02M(-8.2%)
Sep 2002
-
$80.67M(-7.3%)
Jun 2002
-
$87.01M(+180.5%)
Mar 2002
-
$31.02M(-153.6%)
Dec 2001
-$57.88M(+5.0%)
-$57.88M(+10.9%)
Sep 2001
-
-$52.17M(+14.3%)
Jun 2001
-
-$45.63M(+19.4%)
Mar 2001
-
-$38.23M(-30.7%)
Dec 2000
-$55.13M(+115.3%)
-$55.13M(+81.7%)
Sep 2000
-
-$30.34M(+80.5%)
Jun 2000
-
-$16.81M(+33.0%)
Mar 2000
-
-$12.64M(-50.6%)
Dec 1999
-$25.60M(+124.6%)
-$25.60M(-43.1%)
Sep 1999
-
-$45.00M(+48.5%)
Jun 1999
-
-$30.30M(+91.8%)
Mar 1999
-
-$15.80M(+38.6%)
Dec 1998
-$11.40M(-133.2%)
-$11.40M(-256.2%)
Sep 1998
-
$7.30M(-46.7%)
Jun 1998
-
$13.70M(-39.9%)
Mar 1998
-
$22.80M(-33.5%)
Dec 1997
$34.30M(-0.6%)
$34.30M(+113.0%)
Sep 1997
-
$16.10M(-30.3%)
Jun 1997
-
$23.10M(-28.3%)
Mar 1997
-
$32.20M(-6.7%)
Dec 1996
$34.50M(+22.8%)
$34.50M(+305.9%)
Sep 1996
-
$8.50M(-33.1%)
Jun 1996
-
$12.70M(-42.8%)
Mar 1996
-
$22.20M(-21.0%)
Dec 1995
$28.10M(+6.8%)
$28.10M(-14.1%)
Sep 1995
-
$32.70M(+25.3%)
Mar 1995
-
$26.10M(-0.8%)
Dec 1994
$26.30M
$26.30M(-19.6%)
Sep 1994
-
$32.70M(+14.7%)
Jun 1994
-
$28.50M(-20.6%)
Mar 1994
-
$35.90M

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual stockholders equity?
  • What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual stockholders equity?

The current annual shareholders equity of LGND is $830.44M

What is the all time high annual shareholders equity for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual stockholders equity is $830.44M

What is Ligand Pharmaceuticals Incorporated annual shareholders equity year-on-year change?

Over the past year, LGND annual stockholders equity has changed by +$129.53M (+18.48%)

What is Ligand Pharmaceuticals Incorporated quarterly stockholders equity?

The current quarterly shareholders equity of LGND is $795.53M

What is the all time high quarterly shareholders equity for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly stockholders equity is $1.08B

What is Ligand Pharmaceuticals Incorporated quarterly shareholders equity year-on-year change?

Over the past year, LGND quarterly stockholders equity has changed by -$10.99M (-1.36%)
On this page